Pharmacyclics

Featured Drug Company Program


Pharmacyclics YOU&i Support Program

877-877-3536
www.youandisupport.com

Pharmacyclics LLC, an AbbVie Company, together with Janssen Biotech, created a unique set of patient support programs called YOU&i Support. This is a personalized program that helps patients learn about access to Imbruvica (ibrutinib), find affordability support options (Table), and sign up for information and resources to support them along their treatment journey:

  • Contact patients’ insurance provider to help understand benefits
  • Find affordability options to help them afford their treatment
  • Provide educational disease-state information
  • Offer nurse call support that informs patients and responds to their questions.
Table Pharmacyclics Oncology Drugs
Drug Indications Patient support programs Contact information
Imbruvica
(ibrutinib)
Chronic lymphocytic leukemia; small lymphocytic lymphoma YOU&i Instant Savings Program https://webrebate.trialcard.com/coupon/YouAndIInstantSavingsProgram
YOU&i Support Program www.imbruvica.com/patient-support/access-support
Johnson & Johnson Patient Assistance Foundation www.jjpaf.org/eligibility/?medication=IMBRUVICA%C2%AE

YOU&i Instant Savings Program

For commercially insured patients, Pharmacyclics and Janssen Biotech offer the YOU&i Instant Savings Program to help with private insurance copay, deductible, and coinsurance costs for Imbruvica. This program enables eligible patients with commercial insurance to pay a co­pay of $10 per month, regardless of income level.

Eligibility

To be eligible for the YOU&i Instant Savings Program, patients must:

  • Reside in the United States or Puerto Rico
  • Be prescribed Imbruvica
  • Not be enrolled in federal- or state-subsidized healthcare programs that cover prescription drugs, including Medicare, Medicaid, TRICARE, or any other healthcare plan.

YOU&i Start Program

For patients with insurance coverage decision delays, Pharmacyclics and Janssen Biotech offer the YOU&i Start Program. This program offers eligible patients who have been prescribed Imbruvica for an FDA-approved indication, and who are experiencing an insurance coverage decision delay of more than 5 business days, a free 30-day supply of Imbruvica. Under appropriate circumstances, an additional 30-day supply may be provided. The free drug is offered to eligible patients without any purchase contingencies or other obligations.

Independent Foundations

For uninsured patients, the Janssen-affiliated Johnson & Johnson Patient Assistance Foundation, which is an independent, nonprofit organization, may offer assistance with accessing Imbruvica for eligible patients who qualify based on financial need, such as an income requirement of 600% of the federal poverty level.

Application & Enrollment

Enrollment for the YOU&i Support Program can be completed either online at www.youandisupport.com, over the phone at 877-877-3536, or by faxing the enrollment form and related information to 800-752-5896.

Receiving Imbruvica

Imbruvica is dispensed through certain specialty pharmacies, including Avella Specialty Pharmacy, Biologics, Diplomat Specialty Pharmacy, and Onco360, and through the specialty distributors McKesson Specialty Health, Oncology Supply, ASD Healthcare, and McKesson Plasma & Biologics.